Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 560

1.

Redox Signaling in Sickle Cell Disease.

Nolfi-Donegan D, Pradhan-Sundd T, Pritchard KA Jr, Hillery CA.

Curr Opin Physiol. 2019 Jun;9:26-33. doi: 10.1016/j.cophys.2019.04.022. Epub 2019 May 2.

PMID:
31240269
2.

A priori prediction of breast tumour response to chemotherapy using quantitative ultrasound imaging and artificial neural networks.

Tadayyon H, Gangeh M, Sannachi L, Trudeau M, Pritchard K, Ghandi S, Eisen A, Look-Hong N, Holloway C, Wright F, Rakovitch E, Vesprini D, Tran WT, Curpen B, Czarnota G.

Oncotarget. 2019 Jun 11;10(39):3910-3923. doi: 10.18632/oncotarget.26996. eCollection 2019 Jun 11.

3.

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.

Sparano JA, Gray RJ, Ravdin PM, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW Jr.

N Engl J Med. 2019 Jun 20;380(25):2395-2405. doi: 10.1056/NEJMoa1904819. Epub 2019 Jun 3.

PMID:
31157962
4.

A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer.

Robertson JFR, Jiang Z, Di Leo A, Ohno S, Pritchard KI, Ellis M, Bradbury I, Campbell C.

Breast Cancer. 2019 May 11. doi: 10.1007/s12282-019-00973-4. [Epub ahead of print]

PMID:
31079343
5.

Systematic review of orthoses for stroke-induced upper extremity deficits.

Pritchard K, Edelstein J, Zubrenic E, Tsao L, Pustina K, Berendsen M, Wafford E.

Top Stroke Rehabil. 2019 Jul;26(5):389-398. doi: 10.1080/10749357.2019.1599172. Epub 2019 Apr 7.

PMID:
30955481
6.

Policy and Payment Changes Create New Opportunities for Occupational Therapy in Acute Care.

Pritchard KT, Fisher G, McGee Rudnitsky K, Ramirez RD.

Am J Occup Ther. 2019 Mar/Apr;73(2):7302109010p1-7302109010p8. doi: 10.5014/ajot.2018.732002.

PMID:
30915961
7.

Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.

Underwood EA, Jerzak KJ, Lebovic G, Rochon PA, Elser C, Pritchard KI, Tierney MC.

Support Care Cancer. 2019 Aug;27(8):3035-3043. doi: 10.1007/s00520-018-4603-5. Epub 2019 Jan 4.

PMID:
30610433
8.

Dynamic Phosphorylation of the C Terminus of Hsp70 Regulates the Mitochondrial Import of SOD2 and Redox Balance.

Zemanovic S, Ivanov MV, Ivanova LV, Bhatnagar A, Michalkiewicz T, Teng RJ, Kumar S, Rathore R, Pritchard KA Jr, Konduri GG, Afolayan AJ.

Cell Rep. 2018 Nov 27;25(9):2605-2616.e7. doi: 10.1016/j.celrep.2018.11.015.

9.

Bone-Targeted Therapy in Early Breast Cancer.

Jerzak KJ, Raphael J, Desautels DN, Blanchette PS, Tyono I, Pritchard KI.

Oncology (Williston Park). 2018 Nov 15;32(11):562-9. Review.

10.

Analysis of the chief complaints of older patients seeking chiropractic care at a teaching clinic and potential implications for clinical education.

D'cruz D, Clark M, Cade A, Glucina T, Pritchard K, Fox M.

J Chiropr Educ. 2018 Oct;32(2):141-144. doi: 10.7899/JCE-17-25. Epub 2018 Aug 1.

11.

Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study.

Jerzak KJ, Cockburn JG, Dhesy-Thind SK, Pond GR, Pritchard KI, Nofech-Mozes S, Sun P, Narod SA, Bane A.

Breast Cancer Res Treat. 2018 Oct;171(3):709-717. doi: 10.1007/s10549-018-4844-5. Epub 2018 Jun 18.

PMID:
29915948
12.

Preliminary Investigation of Focused Ultrasound-Facilitated Drug Delivery for the Treatment of Leptomeningeal Metastases.

O'Reilly MA, Chinnery T, Yee ML, Wu SK, Hynynen K, Kerbel RS, Czarnota GJ, Pritchard KI, Sahgal A.

Sci Rep. 2018 Jun 13;8(1):9013. doi: 10.1038/s41598-018-27335-y.

13.

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.

Lambertini M, Campbell C, Bines J, Korde LA, Izquierdo M, Fumagalli D, Del Mastro L, Ignatiadis M, Pritchard K, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Barrios CH, Baselga J, Moreno-Aspitia A, Piccart M, Gelber RD, de Azambuja E.

J Natl Cancer Inst. 2019 Jan 1;111(1):86-94. doi: 10.1093/jnci/djy094.

14.

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Goetz MP, Olson JA Jr, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Ravdin PM, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW Jr.

N Engl J Med. 2018 Jul 12;379(2):111-121. doi: 10.1056/NEJMoa1804710. Epub 2018 Jun 3.

15.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B.

Ann Oncol. 2018 Oct 1;29(10):2153. doi: 10.1093/annonc/mdx806. No abstract available.

PMID:
29733336
16.

An update on treatment for post-menopausal metastatic breast cancer in elderly patients.

Menjak IB, Jerzak KJ, Desautels DN, Pritchard KI.

Expert Opin Pharmacother. 2018 Apr;19(6):597-609. doi: 10.1080/14656566.2018.1454431. Review.

PMID:
29601247
17.

Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27.

Strasser-Weippl K, Higgins MJ, Chapman JW, Ingle JN, Sledge GW, Budd GT, Ellis MJ, Pritchard KI, Clemons MJ, Badovinac-Crnjevic T, Han L, Gelmon KA, Rabaglio M, Elliott C, Shepherd LE, Goss PE.

J Natl Cancer Inst. 2018 Sep 1;110(9):1003-1008. doi: 10.1093/jnci/djy017.

18.

Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab.

Blanchette PS, Desautels DN, Pond GR, Bartlett JMS, Nofech-Mozes S, Yaffe MJ, Pritchard KI.

Breast Cancer Res Treat. 2018 Jul;170(1):169-177. doi: 10.1007/s10549-018-4734-x. Epub 2018 Mar 8.

PMID:
29520532
19.

Differences in learning retention when teaching a manual motor skill with a visual vs written instructional aide.

Cade A, Sherson M, Holt K, Dobson G, Pritchard K, Haavik H.

J Chiropr Educ. 2018 Oct;32(2):107-114. doi: 10.7899/JCE-17-19. Epub 2018 Feb 21.

20.

Prospective Evaluation of the Impact of the 21-Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node-Positive Breast Cancer in Ontario, Canada.

Torres S, Trudeau M, Gandhi S, Warner E, Verma S, Pritchard KI, Petrella T, Hew-Shue M, Chao C, Eisen A.

Oncologist. 2018 Jul;23(7):768-775. doi: 10.1634/theoncologist.2017-0346. Epub 2018 Jan 25.

21.

Phosphoinositide 3-kinase inhibitors in advanced breast cancer: A systematic review and meta-analysis.

Raphael J, Desautels D, Pritchard KI, Petkova E, Shah PS.

Eur J Cancer. 2018 Mar;91:38-46. doi: 10.1016/j.ejca.2017.12.010. Epub 2018 Jan 11. Review.

PMID:
29331750
22.

Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years.

Lemieux J, Brundage MD, Parulekar WR, Goss PE, Ingle JN, Pritchard KI, Celano P, Muss H, Gralow J, Strasser-Weippl K, Whelan K, Tu D, Whelan TJ.

J Clin Oncol. 2018 Feb 20;36(6):563-571. doi: 10.1200/JCO.2017.75.7500. Epub 2018 Jan 12. Erratum in: J Clin Oncol. 2018 May 20;36(15):1540.

23.

Multisector Partnerships Need Further Development To Fulfill Aspirations For Transforming Regional Health And Well-Being.

Siegel B, Erickson J, Milstein B, Pritchard KE.

Health Aff (Millwood). 2018 Jan;37(1):30-37. doi: 10.1377/hlthaff.2017.1118.

PMID:
29309220
24.

Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis.

Underwood EA, Rochon PA, Moineddin R, Lee PE, Wu W, Pritchard KI, Tierney MC.

Breast Cancer Res Treat. 2018 Apr;168(2):299-310. doi: 10.1007/s10549-017-4627-4. Epub 2017 Dec 20. Review.

PMID:
29264751
25.

Incidence of suicide, hospital-presenting non-fatal self-harm, and community-occurring non-fatal self-harm in adolescents in England (the iceberg model of self-harm): a retrospective study.

Geulayov G, Casey D, McDonald KC, Foster P, Pritchard K, Wells C, Clements C, Kapur N, Ness J, Waters K, Hawton K.

Lancet Psychiatry. 2018 Feb;5(2):167-174. doi: 10.1016/S2215-0366(17)30478-9. Epub 2017 Dec 12.

PMID:
29246453
26.

Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27.

Niravath P, Chen B, Chapman JW, Agarwal SK, Welschhans RL, Bongartz T, Kalari KR, Shepherd LE, Bartlett J, Pritchard K, Gelmon K, Hilsenbeck SG, Rimawi MF, Osborne CK, Goss PE, Ingle JN.

Clin Breast Cancer. 2018 Feb;18(1):78-87. doi: 10.1016/j.clbc.2017.10.009. Epub 2017 Oct 16.

PMID:
29128193
27.

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF; EBCTCG.

N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830.

28.

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.

Dubsky P, Curigliano G, Burstein HJ, Winer EP, Gnant M, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B; Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017, André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B.

Ann Oncol. 2018 Jan 1;29(1):281-282. doi: 10.1093/annonc/mdx543. No abstract available.

29.

Extended adjuvant therapy: the role of subset analyses.

Pritchard KI.

Lancet Oncol. 2017 Nov;18(11):1431-1433. doi: 10.1016/S1470-2045(17)30787-8. Epub 2017 Oct 12. No abstract available.

PMID:
29031779
30.

Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis.

Raphael J, Helou J, Pritchard KI, Naimark DM.

Eur J Cancer. 2017 Nov;85:146-154. doi: 10.1016/j.ejca.2017.08.018. Epub 2017 Sep 18.

PMID:
28930692
31.

Chemotherapy-Response Monitoring of Breast Cancer Patients Using Quantitative Ultrasound-Based Intra-Tumour Heterogeneities.

Sadeghi-Naini A, Sannachi L, Tadayyon H, Tran WT, Slodkowska E, Trudeau M, Gandhi S, Pritchard K, Kolios MC, Czarnota GJ.

Sci Rep. 2017 Sep 4;7(1):10352. doi: 10.1038/s41598-017-09678-0.

32.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B; St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017, André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Hussein K, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B.

Ann Oncol. 2017 Aug 1;28(8):1700-1712. doi: 10.1093/annonc/mdx308. Erratum in: Ann Oncol. 2018 Oct 1;29(10):2153. Ann Oncol. 2019 Jan 9;:.

33.

African American Fathers' Occupational Participation: "Keeping the Mothers in a Positive Vibe".

Pizur-Barnekow K, Pate D, Lazar K, Paul N, Pritchard K, Morris G.

OTJR (Thorofare N J). 2017 Oct;37(4):237-244. doi: 10.1177/1539449217714236. Epub 2017 Jul 14.

PMID:
28709392
34.

Correction: Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach.

Tadayyon H, Sannachi L, Gangeh M, Sadeghi-Naini A, Tran W, Trudeau ME, Pritchard K, Ghandi S, Verma S, Czarnota GJ.

Oncotarget. 2017 May 23;8(21):35481. doi: 10.18632/oncotarget.18068. No abstract available.

35.

Myeloperoxidase: A new player in autoimmunity.

Strzepa A, Pritchard KA, Dittel BN.

Cell Immunol. 2017 Jul;317:1-8. doi: 10.1016/j.cellimm.2017.05.002. Epub 2017 May 10. Review.

36.

Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.

Lipton A, Chapman JW, Leitzel K, Garg A, Pritchard KI, Ingle JN, Budd GT, Ellis MJ, Sledge GW, Rabaglio M, Han L, Elliott CR, Shepherd LE, Goss PE, Ali SM.

Cancer. 2017 Jul 1;123(13):2444-2451. doi: 10.1002/cncr.30682. Epub 2017 May 2.

37.

Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32.

Lohmann AE, Liebman MF, Brien W, Parulekar WR, Gelmon KA, Shepherd LE, Ligibel JA, Hershman DL, Rastogi P, Mayer IA, Hobday TJ, Lemieux J, Thompson AM, Pritchard KI, Whelan TJ, Mukherjee SD, Chalchal HI, Bernstein V, Stambolic V, Chen BE, Goodwin PJ; From the CCTG, Alliance, SWOG, ECOG, NSABP Cooperative Groups.

Breast Cancer Res Treat. 2017 Jul;164(2):371-378. doi: 10.1007/s10549-017-4265-x. Epub 2017 Apr 26.

38.

A priori Prediction of Neoadjuvant Chemotherapy Response and Survival in Breast Cancer Patients using Quantitative Ultrasound.

Tadayyon H, Sannachi L, Gangeh MJ, Kim C, Ghandi S, Trudeau M, Pritchard K, Tran WT, Slodkowska E, Sadeghi-Naini A, Czarnota GJ.

Sci Rep. 2017 Apr 12;7:45733. doi: 10.1038/srep45733.

39.

Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials.

Yerushalmi R, Dong B, Chapman JW, Goss PE, Pollak MN, Burnell MJ, Levine MN, Bramwell VHC, Pritchard KI, Whelan TJ, Ingle JN, Shepherd LE, Parulekar WR, Han L, Ding K, Gelmon KA.

Ann Oncol. 2017 Jul 1;28(7):1560-1568. doi: 10.1093/annonc/mdx152.

40.

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice.

Weihrauch D, Krolikowski JG, Jones DW, Zaman T, Bamkole O, Struve J, Pagel PS, Lohr NL, Pritchard KA Jr.

J Vis Exp. 2017 Mar 24;(121). doi: 10.3791/55036.

41.

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

Taylor C, Correa C, Duane FK, Aznar MC, Anderson SJ, Bergh J, Dodwell D, Ewertz M, Gray R, Jagsi R, Pierce L, Pritchard KI, Swain S, Wang Z, Wang Y, Whelan T, Peto R, McGale P; Early Breast Cancer Trialists’ Collaborative Group.

J Clin Oncol. 2017 May 20;35(15):1641-1649. doi: 10.1200/JCO.2016.72.0722. Epub 2017 Mar 20.

42.

Does adjuvant radiation therapy benefit women with small mammography-detected breast cancers?

Jerzak K, Dudalski N, Pritchard K, Sun P, Narod SA.

Curr Oncol. 2017 Feb;24(1):28-32. doi: 10.3747/co.24.3089. Epub 2017 Feb 27.

43.

Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial.

Smith I, Yardley D, Burris H, De Boer R, Amadori D, McIntyre K, Ejlertsen B, Gnant M, Jonat W, Pritchard KI, Dowsett M, Hart L, Poggio S, Comarella L, Salomon H, Wamil B, O'Shaughnessy J.

J Clin Oncol. 2017 Apr 1;35(10):1041-1048. doi: 10.1200/JCO.2016.69.2871. Epub 2017 Jan 23. Erratum in: J Clin Oncol. 2019 Feb 1;37(4):359.

PMID:
28113032
44.

Domain Mapping of Heat Shock Protein 70 Reveals That Glutamic Acid 446 and Arginine 447 Are Critical for Regulating Superoxide Dismutase 2 Function.

Afolayan AJ, Alexander M, Holme RL, Michalkiewicz T, Rana U, Teng RJ, Zemanovic S, Sahoo D, Pritchard KA Jr, Konduri GG.

J Biol Chem. 2017 Feb 10;292(6):2369-2378. doi: 10.1074/jbc.M116.756122. Epub 2016 Dec 27.

45.

Plasma vascular endothelial growth factor as a predictive biomarker: Door closed?

Rana P, Pritchard KI, Kerbel R.

Eur J Cancer. 2017 Jan;70:143-145. doi: 10.1016/j.ejca.2016.11.002. Epub 2016 Dec 2. No abstract available.

PMID:
27916568
46.

Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.

Pritchard KI, Chia SK, Simmons C, McLeod D, Paterson A, Provencher L, Rayson D.

Oncologist. 2017 Jan;22(1):12-24. doi: 10.1634/theoncologist.2016-0185. Epub 2016 Nov 18.

47.

The loss of self: The effect of miscarriage, stillbirth, and child death on maternal self-esteem.

Wonch Hill P, Cacciatore J, Shreffler KM, Pritchard KM.

Death Stud. 2017 Apr;41(4):226-235. doi: 10.1080/07481187.2016.1261204. Epub 2016 Nov 17.

PMID:
27854184
48.

Do aromatase inhibitors increase cardiovascular risk? Piecing together the evidence.

Desautels DN, Blanchette PS, Pritchard KI.

Eur J Cancer. 2016 Nov;68:176-178. doi: 10.1016/j.ejca.2016.09.007. Epub 2016 Oct 21. No abstract available.

PMID:
27776294
49.

The 21-gene recurrence score assay in node-negative early breast cancer: Prognostic, predictive or presumptuous?

Jerzak KJ, Pritchard KI.

Eur J Cancer. 2016 Nov;68:173-175. doi: 10.1016/j.ejca.2016.08.021. Epub 2016 Oct 19. No abstract available.

PMID:
27768924
50.

Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy.

Ingle JN, Xie F, Ellis MJ, Goss PE, Shepherd LE, Chapman JW, Chen BE, Kubo M, Furukawa Y, Momozawa Y, Stearns V, Pritchard KI, Barman P, Carlson EE, Goetz MP, Weinshilboum RM, Kalari KR, Wang L.

Cancer Res. 2016 Dec 1;76(23):7012-7023. Epub 2016 Oct 10.

Supplemental Content

Loading ...
Support Center